Proepicardium: Current Understanding of its Structure, Induction, and Fate.


Journal

Anatomical record (Hoboken, N.J. : 2007)
ISSN: 1932-8494
Titre abrégé: Anat Rec (Hoboken)
Pays: United States
ID NLM: 101292775

Informations de publication

Date de publication:
06 2019
Historique:
received: 09 10 2017
revised: 20 08 2018
accepted: 30 08 2018
pubmed: 14 11 2018
medline: 7 7 2020
entrez: 14 11 2018
Statut: ppublish

Résumé

The proepicardium (PE) is a transitory extracardiac embryonic structure which plays a crucial role in cardiac morphogenesis and delivers various cell lineages to the developing heart. The PE arises from the lateral plate mesoderm (LPM) and is present in all vertebrate species. During development, mesothelial cells of the PE reach the naked myocardium either as free-floating aggregates in the form of vesicles or via a tissue bridge; subsequently, they attach to the myocardium and, finally, form the third layer of a mature heart-the epicardium. After undergoing epithelial-to-mesenchymal transition (EMT) some of the epicardial cells migrate into the myocardial wall and differentiate into fibroblasts, smooth muscle cells, and possibly other cell types. Despite many recent findings, the molecular pathways that control not only proepicardial induction and differentiation but also epicardial formation and epicardial cell fate are poorly understood. Knowledge about these events is essential because molecular mechanisms that occur during embryonic development have been shown to be reactivated in pathological conditions, for example, after myocardial infarction, during hypertensive heart disease or other cardiovascular diseases. Therefore, in this review we intended to summarize the current knowledge about PE formation and structure, as well as proepicardial cell fate in animals commonly used as models for studies on heart development. Anat Rec, 302:893-903, 2019. © 2018 Wiley Periodicals, Inc.

Identifiants

pubmed: 30421563
doi: 10.1002/ar.24028
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

893-903

Subventions

Organisme : National Science Center (NCN)
ID : N N401 270139
Pays : International
Organisme : Medical University of Warsaw
ID : 1M11
Pays : International
Organisme : Medical University of Warsaw
ID : 1M15
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Justyna Niderla-BieliŃska (J)

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.

Ewa Jankowska-Steifer (E)

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.

Aleksandra Flaht-Zabost (A)

Department of Pathology, Medical University of Warsaw, Warsaw, Poland.

Grzegorz Gula (G)

Department of Pathology, Medical University of Warsaw, Warsaw, Poland.
The Postgraduate School of Molecular Medicine (SMM), Warsaw, Poland.

Elżbieta Czarnowska (E)

Department of Pathology, The Children's Memorial Health Institute, Warsaw, Poland.

Anna Ratajska (A)

Department of Pathology, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH